News

In a bid to enhance portfolio of flow-based detection, Luminex Corporation LMNX recently announced the acquisition of MilliporeSigma's flow cytometry portfolio. The deal, announced earlier in ...
AUSTIN, Texas, Oct. 18, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that the company has signed a definitive agreement to acquire MilliporeSigma's flow cytometry ...
Luminex Corporat Brian Hall, Product Manager, Imaging Flow Cytometry,1 Stephanie Brunelle, PhD, Product Manager, CellStream,1 Katie Gillis, Product Manager, Microcapillary Flow Cytometry2 1. toggle ...
The flow cytometers and reagents developed by Luminex “combine the power of flow cytometry with the simplicity of an ELISA plate reader,” says Grant Gibson, director of scientific alliances.
US biotech company Luminex, which develops imaging and testing technologies for diverse life-science applications, is to acquire MilliporeSigma's flow cytometry portfolio in a deal valued at $75 ...
Luminex Corporation (LMNX) Luminex Corporation to Acquire MilliporeSigma’s Flow Cytometry Portfolio October 18, 2018 8:30 AM ET. Executives. Harriss Currie – Senior Vice President and Chief ...
Some flow cytometry trends are peaking, ... The current versions of these instruments, which are available from the Amnis division of Luminex, ...
Dublin, Oct. 19, 2021 (GLOBE NEWSWIRE) -- The "Flow Cytometry Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets ...
Sale of assets related to Flow Cytometry & Imaging (FCI) Business Unit Acquisition will expand Cytek’s product portfolio to include imaging and menu-based application driven flow cytometry to ...
I n a bid to enhance portfolio of flow-based detection, Luminex CorporationLMNX recently announced the acquisition of MilliporeSigma's flow cytometry portfolio. The deal, announced earlier in ...
We will also show more traditional flow cytometry approaches to cellular-based assays, including accurate count and viability determination of peripheral blood mononuclear cells (PBMCs), ...